Hepatitis A vaccine shortage in Canada

According to vaccine manufacturers, Canada is facing a shortage of hepatitis A vaccine due to increased demand and shipping delays that may continue into the spring. , GlaxoSmithKline (GSK) and Merck are produced.

Health Canada announced Wednesday that all three companies have reported shortages of at least one vaccine for hepatitis A. Hepatitis A is a viral infection that mainly affects the liver. According to the Ministry of Health, it is usually transmitted through consumption of contaminated food or water, or close contact with an infected person (via faeces).

Raw fruits and vegetables as well as raw or undercooked shellfish are common food sources of hepatitis A transmission. People can be carriers of this virus without having any symptoms and pass it on to others. Its common symptoms include fever, loss of appetite, stomach pain, jaundice, dark urine and fatigue.

Although it is rare for healthy adults to die from this virus, hepatitis A can be fatal for pregnant women, especially in the third trimester. The hepatitis A vaccine must be administered in two doses. One dose of the vaccine should be given for primary immunization and the second dose should be given at least 6 to 36 months later.

This vaccine is recommended for immunizing people six months and older. The vaccine is also recommended for travelers to countries with high incidence of hepatitis A, those with chronic liver disease, and men who have sex with men.

news source